Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists

The synthesis and biological optimization for 5,6-diarylpyridines as CB1 receptor inverse agonists is described. Optimization of the biological activity for 5,6-diarylpyridines as CB1 receptor inverse agonists is described. Food intake and pharmacokinetic evaluation of 3f and 15c indicate that these...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2007-04, Vol.17 (7), p.2031-2035
Hauptverfasser: Madsen-Duggan, Christina B., Debenham, John S., Walsh, Thomas F., Toupence, Richard B., Huang, Song X., Wang, Junying, Tong, Xinchun, Lao, Julie, Fong, Tung M., Schaeffer, Marie-Therese, Xiao, Jing Chen, Huang, Cathy R.-R.C., Shen, Chun-Pyn, Stribling, D. Sloan, Shearman, Lauren P., Strack, Alison M., MacIntyre, D. Euan, Van der Ploeg, Lex H.T., Goulet, Mark T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The synthesis and biological optimization for 5,6-diarylpyridines as CB1 receptor inverse agonists is described. Optimization of the biological activity for 5,6-diarylpyridines as CB1 receptor inverse agonists is described. Food intake and pharmacokinetic evaluation of 3f and 15c indicate that these compounds are effective orally active modulators of CB1.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2007.01.005